MEK inhibition suppresses metastatic progression of KRAS ‐mutated gastric cancer-Reference-Cited by-同舟云学术

MEK inhibition suppresses metastatic progression of KRAS ‐mutated gastric cancer

Published:2022-01-07 Issue: Volume: Page:
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Yamasaki Juntaro¹,Hirata Yuki²,Otsuki Yuji¹,Suina Kentaro¹,Saito Yoshiyuki²^ORCID,Masuda Kenta³^ORCID,Okazaki Shogo⁴,Ishimoto Takatsugu⁵^ORCID,Saya Hideyuki¹,Nagano Osamu¹^ORCID

Affiliation:

1. Division of Gene Regulation Institute for Advanced Medical Research School of Medicine Keio University Tokyo Japan

2. Department of Surgery School of Medicine Keio University Tokyo Japan

3. Department of Obstetrics and Gynecology School of Medicine Keio University Tokyo Japan

4. Division of Development and Aging Research Institute for Biomedical SciencesTokyo University of Science Noda Japan

5. Gastrointestinal Cancer Biology International Research Center for Medical Sciences (IRCMS) Kumamoto University Kumamoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15244

Reference43 articles.

1. The two histological main types of gastric carcinoma: diffuse and so‐called intestinal‐type carcinoma. an attempt at a histo‐clinical classification;Lauren P;Acta Pathol Microbiol Scand,1965

2. Comprehensive molecular characterization of gastric adenocarcinoma;Cancer genome atlas research N;Nature,2014

3. p53 mutations in human cancers;Hollstein M;Science,1991

4. TP53 and gastric carcinoma: a review;Fenoglio‐Preiser CM;Hum Mutat,2003

5. The critical driver and therapeutic target for pancreatic cancer;Waters AM;Cold Spring Harb Perspect Med,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of spatial omics in gastric cancer;Pathology - Research and Practice;2024-10

2. Microfluidic systems for modeling digestive cancer: a review of recent progress;Biomedical Physics & Engineering Express;2024-08-28

3. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development;Trends in Cancer;2024-07

4. RAC1-mediated integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination;Cancer Letters;2024-06

5. Applications of single‑cell omics and spatial transcriptomics technologies in gastric cancer (Review);Oncology Letters;2024-02-14